Randomized controlled smoking cessation study: Transient increase in plasma high density lipoprotein but no change in lipoprotein oxidation resistance

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 58, Issue 1, 1998, Pages 11-18

  Prieme H ^a   Nyyssonen K ^d   Gronbaek K ^b   Klarlund, M ^b   Loft, S ^a   Tonnesen P ^b   Salonen, J T ^d   Poulsen, H E ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Lag time; lipoprotein peroxidation; Plasma lipids and lipoproteins; Smoking

Indexed keywords

HIGH DENSITY LIPOPROTEIN; NICOTINE; NICOTINE GUM;

ADDICTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031885770     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519850186788     Document Type: Article

References (30)

1. Hammond EC. Smoking in relation to the death rates of one million men and women. National Cancer Institute Monographs 1966; 19: 127-204.
2. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 1994; 309: 901-10.
3. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. HDL as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-14.
4. Miller NE, Førde OH, Thelle DS, Mjøs OD. The Trosmø Heart Study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977; 1: 965-7.
5. Garrison RJ, Kannel WB, Feinleib M, Castelli WP, McNamara PM, Padgett SJ. Cigarette smoking and HDL cholesterol. The Framingham Offspring Study. Atherosclerosis 1978; 30: 17-25.
6. Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GTL. Cigarette smoking and plasma high-density lipoprotein cholesterol. Circulation 1980; 62 Suppl 4: 70-6.
7. Mjøs OD. Lipid effects of smoking. Am Heart J 1988; 115: 272-5.
8. Brischetto CS, Connor WE, Connor SL, Matarazzo JD. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein. Am J Cardiol 1983; 52: 675-80.
9. Allen SS, Hatsukami D, Gorsline J and the Transdermal Nicotine Study Group. Cholesterol changes in smoking cessation using the trans-dermal nicotine system. Prev Med 1994; 23: 190-6.
10. Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. Am J Med 1994; 97: 242-9.
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
12. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-6.
13. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111-26.
14. Pryor WA, Prier DG, Church DF. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gasphase smoke and in cigarette tar. Environ Health Perspect 1983; 47: 345-55.
15. Kalra J, Chaudhary AK, Prasad K. Increased production of oxygen free radicals in cigarette smokers. Int J Exp Path 1991; 72: 1-7.
16. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Frans JK. Supplementation with vitamin E hut not beta-catotene in vivo protects LDL from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992; 12: 554-62.
17. Tønnesen P, Nørregaard J, Simonsen K, Säwe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-5.
18. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-82.
19. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Nyyssönen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistance of alherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial. Eur J Clin Nutr 1994; 48: 633-42.
21. Freeman DJ, Packard CJ. Smoking and plasma lipoprotein metabolism. Clin Sci 1995; 89: 333-42.
22. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989; 298: 784-8.
23. Stubbe I, Eskilsson J, Nilsson-Ehle P. Highdensity lipoprolein concentrations increase after stopping smoking. Br Med J 1982; 284: 1511-3.
24. Gerace TA, Hollis J, Ockene JK, Svendsen K. For the MRFIT Research Group. Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. Prev Med 1991; 20: 602-20.
25. Rabkin SW. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. Atherosclerosis 1984; 53: 173-84.
26. Nilsson P, Lundgren H, Söderström M, Fagerström K-O, Nilsson-Ehle P. Effects of smoking cessation on insulin and cardiovascular risk factors - a controlled study of 4 months' duration. J Intern Med 1996; 240: 189-94.
27. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms 1989; 6: 67-75.
28. Brown AJ. Acute effects of smoking on antioxidant status. J Nutr Biochem 1996; 7: 29-39.
29. Quensel M, Agardh C-D, Nilsson-Ehle P. Nicotine does not affect plasma lipoprotein concentrations in healthy men. Scand J Clin Lab Invest 1989; 49: 149-53.
30. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.